Skip to main content

Columbia to cut ties to Biosphere 2

Departure from Arizona facility leaves future of research there uncertain

Written byMaria Anderson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

Columbia University on Monday (September 8) announced that, effective December 22, its researchers would leave the troubled Biosphere 2. Columbia will cut its 7-year ties to the Oracle, Ariz., facility as part of the settlement of a lawsuit against them by Biosphere 2's owners, Decisions Investments Corporation.

The suit, filed in March, claimed that Columbia had failed to hire six full-time research faculty members, ended plans to build a new lab, and cut financial backing of the facility. Columbia sends approximately 200 students each year to Biosphere 2 to attend classes and conduct research with the resident scientists, but all educational programs will be discontinued at the end of this semester. Columbia has also requested that all research equipment, including custom-made instruments, be returned to the university by the end of this year.

What will happen next is uncertain. "Right now, we're turning our attention to exploring viable options for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays